The microRNA miR-124 inhibits vascular smooth muscle cell proliferation by targeting S100 calcium-binding protein A4 (S100A4)

FEBS Letters

Volumn 591, Issue 7, 2017, Pages 1041-1052

  Choe, Nakwon ^a   Kwon, Duk Hwa ^a   Shin, Sera ^a   Kim, Yong Sook ^b   Kim, Young Kook ^a   Kim, Jaetaek ^a,c   Ahn, Youngkeun ^b   Eom, Gwang H ^a   Kook, Hyun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

carotid artery injury; miR 124; neointima; S100A4; vascular smooth muscle cell proliferation

Indexed keywords

CALVASCULIN; MICRORNA 124; SMALL INTERFERING RNA; 3' UNTRANSLATED REGION; MICRORNA; MIRN124 MICRORNA, RAT; S100A4 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOINFORMATICS; CAROTID ARTERY INJURY; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; GENE FUNCTION; IN VITRO STUDY; LETTER; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; VASCULAR SMOOTH MUSCLE CELL; 3' UNTRANSLATED REGION; ANIMAL; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOINTIMA; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; TIME FACTOR; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CAROTID ARTERY INJURIES; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; S100 CALCIUM-BINDING PROTEIN A4; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS;

EID: 85016429201     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12606     Document Type: Article

References (44)

1. Johnson JL (2014) Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. Cardiovasc Res 103, 452–460.
2. Marenholz I, Heizmann CW and Fritz G (2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322, 1111–1122.
3. Sherbet GV (2009) Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 280, 15–30.
4. Brisset AC, Hao H, Camenzind E, Bacchetta M, Geinoz A, Sanchez JC, Chaponnier C, Gabbiani G and Bochaton-Piallat ML (2007) Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 100, 1055–1062.
5. Coen M, Burkhardt K, Bijlenga P, Gabbiani G, Schaller K, Kovari E, Rufenacht DA, Ruiz DS, Pizzolato G and Bochaton-Piallat ML (2013) Smooth muscle cells of human intracranial aneurysms assume phenotypic features similar to those of the atherosclerotic plaque. Cardiovasc Pathol 22, 339–344.
6. Mishra SK, Siddique HR and Saleem M (2012) S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev 31, 163–172.
7. Lawrie A, Spiekerkoetter E, Martinez EC, Ambartsumian N, Sheward WJ, MacLean MR, Harmar AJ, Schmidt AM, Lukanidin E and Rabinovitch M (2005) Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res 97, 227–235.
8. Spiekerkoetter E, Guignabert C, de Jesus Perez V, Alastalo TP, Powers JM, Wang L, Lawrie A, Ambartsumian N, Schmidt AM, Berryman M et al. (2009) S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ Res 105, 639–647, 13 p following 647.
9. Chaabane C, Heizmann CW and Bochaton-Piallat ML (2015) Extracellular S100A4 induces smooth muscle cell phenotypic transition mediated by RAGE. Biochim Biophys Acta 1853, 2144–2157.
10. Krutzfeldt J (2016) Strategies to use microRNAs as therapeutic targets. Best Pract Res Clin Endocrinol Metab 30, 551–561.
11. Ambros V (2004) The functions of animal microRNAs. Nature 431, 350–355.
12. Choe N, Kwon JS, Kim JR, Eom GH, Kim Y, Nam KI, Ahn Y, Kee HJ and Kook H (2013) The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 229, 348–355.
13. Choe N, Kwon JS, Kim YS, Eom GH, Ahn YK, Baik YH, Park HY and Kook H (2015) The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor. Cell Signal 27, 1056–1065.
14. Dahlmann M, Okhrimenko A, Marcinkowski P, Osterland M, Herrmann P, Smith J, Heizmann CW, Schlag PM and Stein U (2014) RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis. Oncotarget 5, 3220–3233.
15. Wang XG, Meng Q, Qi FM and Yang QF (2014) Blocking TGF-beta inhibits breast cancer cell invasiveness via ERK/S100A4 signal. Eur Rev Med Pharmacol Sci 18, 3844–3853.
16. Li L, Luo J, Wang B, Wang D, Xie X, Yuan L, Guo J, Xi S, Gao J, Lin X et al. (2013) Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer 12, 163.
17. Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33, 637–668.
18. Zimmer DB, Cornwall EH, Landar A and Song W (1995) The S100 protein family: history, function, and expression. Brain Res Bull 37, 417–429.
19. Kriajevska M, Tarabykina S, Bronstein I, Maitland N, Lomonosov M, Hansen K, Georgiev G and Lukanidin E (1998) Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J Biol Chem 273, 9852–9856.
20. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G et al. (2001) Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276, 22699–22708.
21. Mocellin S, Zavagno G and Nitti D (2008) The prognostic value of serum S100B in patients with cutaneous melanoma: a meta-analysis. Int J Cancer 123, 2370–2376.
22. Bloomfield SM, McKinney J, Smith L and Brisman J (2007) Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 6, 121–138.
23. Dassan P, Keir G and Brown MM (2009) Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis 27, 295–302.
24. Novitskaya V, Grigorian M, Kriajevska M, Tarabykina S, Bronstein I, Berezin V, Bock E and Lukanidin E (2000) Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem 275, 41278–41286.
25. Li ZH and Bresnick AR (2006) The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res 66, 5173–5180.
26. Schmidt-Hansen B, Ornas D, Grigorian M, Klingelhofer J, Tulchinsky E, Lukanidin E and Ambartsumian N (2004) Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 23, 5487–5495.
27. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6, 14.
28. Li KK, Pang JC, Ching AK, Wong CK, Kong X, Wang Y, Zhou L, Chen Z and Ng HK (2009) miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40, 1234–1243.
29. Dong LL, Chen LM, Wang WM and Zhang LM (2015) Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer. Diagn Pathol 10, 45.
30. Li X, Yu Z, Li Y, Liu S, Gao C, Hou X, Yao R and Cui L (2015) The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients. Int J Oncol 46, 798–808.
31. Liu S, Hu C, Wang Y, Shi G, Li Y and Wu H (2016) miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3. Oncol Rep 36, 2398–2404.
32. Xu S, Zhao N, Hui L, Song M, Miao ZW and Jiang XJ (2016) MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3. Oncol Rep 35, 1385–1394.
33. Xi ZW, Xin SY, Zhou LQ, Yuan HX, Wang Q and Chen KX (2015) Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer. World J Gastroenterol 21, 5454–5464.
34. An L, Liu Y, Wu A and Guan Y (2013) microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma. PLoS One 8, e69478.
35. Feng T, Xu D, Tu C, Li W, Ning Y, Ding J, Wang S, Yuan L, Xu N, Qian K et al. (2015) MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. Tumour Biol 36, 5987–5997.
36. Zhang T, Wang J, Zhai X, Li H, Li C and Chang J (2014) MiR-124 retards bladder cancer growth by directly targeting CDK4. Acta Biochim Biophys Sin (Shanghai) 46, 1072–1079.
37. Kang K, Peng X, Zhang X, Wang Y, Zhang L, Gao L, Weng T, Zhang H, Ramchandran R, Raj JU et al. (2013) MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells. J Biol Chem 288, 25414–25427.
38. Bienertova-Vasku J, Novak J and Vasku A (2015) MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment. J Am Soc Hypertens 9, 221–234.
39. Zeng J, Xiong Y, Li G, Liu M, He T, Tang Y, Chen Y, Cai L, Jiang R and Tao J (2013) MiR-21 is overexpressed in response to high glucose and protects endothelial cells from apoptosis. Exp Clin Endocrinol Diabetes 121, 425–430.
40. Dou C, Liu Z, Xu M, Jia Y, Wang Y, Li Q, Yang W, Zheng X, Tu K and Liu Q (2016) miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4. Cancer Lett 381, 380–390.
41. Li P, Zhu N, Yi B, Wang N, Chen M, You X, Zhao X, Solomides CC, Qin Y and Sun J (2013) MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res 113, 1117–1127.
42. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES and Zhang C (2009) MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105, 158–166.
43. Liu YF, Spinelli A, Sun LY, Jiang M, Singer DV, Ginnan R, Saddouk FZ, Van RD and Singer HA (2016) MicroRNA-30 inhibits neointimal hyperplasia by targeting Ca(2+)/calmodulin-dependent protein kinase IIdelta (CaMKIIdelta). Sci Rep 6, 26166.
44. Li Y, McRobb LS and Khachigian LM (2016) MicroRNA miR-191 targets the zinc finger transcription factor Egr-1 and suppresses intimal thickening after carotid injury. Int J Cardiol 212, 299–302.